SCHEMBL257496

SCHEMBL257496

CCOC(=O)c1c(C)cc(C(=O)c2ccccc2)n1CC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.48
GAA P10253 3/20 0.48
MAPT P10636 2/20 0.48
KMT2A Q03164 3/20 0.47
MEN1 O00255 2/20 0.47
TSHR P16473 4/20 0.46
PTGS2 P35354 1/20 0.43
KDM4E B2RXH2 3/20 0.43
HPGD P15428 2/20 0.43
SIRT3 Q9NTG7 1/20 0.43
HSD17B10 Q99714 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
NPC1 O15118 5/20 0.42
SMN1; SMN2 Q16637 5/20 0.42
RAB9A P51151 4/20 0.42
NFKB1 P19838 2/20 0.42
NFKB2 Q00653 2/20 0.42
RELA Q04206 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL257495 0.87 FNTA (0.45) ALDH1A1MAPTKMT2AMEN1TSHR
SCHEMBL15197144 0.86 FNTA (0.41) ALDH1A1GAAMAPTKMT2AMEN1
SCHEMBL256764 0.84 ALDH1A1 (0.49) ALDH1A1GAAMAPTKMT2AMEN1
SCHEMBL16246750 0.76 F10 (0.43) ALDH1A1MAPTKMT2AMEN1TSHR
SCHEMBL10940170 0.75 SMN1; SMN2 (0.47) ALDH1A1GAAMAPTKMT2AMEN1
SCHEMBL29123133 0.73 TSHR (0.71) ALDH1A1GAAMAPTKMT2AMEN1
SCHEMBL15100671 0.72 ALDH1A1 (0.45) ALDH1A1GAAMAPTKMT2AMEN1
SCHEMBL571222 0.72 SMN1; SMN2 (0.66) ALDH1A1GAAMAPTKMT2AMEN1
SCHEMBL5609240 0.72 TSHR (0.58) ALDH1A1GAAMAPTKMT2ATSHR
SCHEMBL13679134 0.71 RAB9A (0.46) ALDH1A1GAAMAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895552-B2 Cyclic amide derivative SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2014-11-25 US disclosed
US-20130217692-A1 CYCLIC AMIDE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2013-08-22 US disclosed
EP-2612848-A1 CYCLIC AMIDE DERIVATIVE Dainippon Sumitomo Pharma Co., Ltd. (JP) 2013-07-10 EP disclosed
WO-2012029942-A1 CYCLIC AMIDE DERIVATIVE 大日本住友製薬株式会社 (JP) 2012-03-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130217692-A1 CYCLIC AMIDE DERIVATIVE HDAC10, H1-10, H1-0 ALDH1A1 538/4885GAA 4354/4885MAPT 3973/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.